Clínic-IDIBAPS researchers have coordinated two review articles on hepatocellular carcinoma (HCC), the most common type of liver cancer, in which the1
The goal of the initiative is to explore the potential of new artificial-intelligence tools to improve current imaging solutions for cancer cases.
Researchers from IDIBAPS-Hospital Clínic and CNAG-CRG in Barcelona have led a study to draw the first 3D maps of the genome of healthy and cancerous1
The University of Barcelona, Hospital Clínic and the pharmaceutical company AstraZeneca created the UB-Hospital Clínic Chair on Lung Cancer AstraZene1
Spanish investigators from the IDIBAPS-Hospital Clínic of Barcelona have led an international effort to develop an epigenetic clock that is able to t1
Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating h1
In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘immun1
Researchers from the IDIBAPS Research Institute have found that the protein known as ZEB1 have beneficial or deleterious effects depending on its lev1
